Literature DB >> 28326587

Editorial: co-existing immune-mediated disease in inflammatory bowel diseases - a new disease severity indicator? Author's reply.

A N Ananthakrishnan1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28326587      PMCID： PMC5363278          DOI： 10.1111/apt.13998

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  3 in total

1.  The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.

Authors:  G Conway; G Velonias; E Andrews; J J Garber; V Yajnik; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2017-01-20       Impact factor: 8.171

2.  Editorial: co-existing immune-mediated disease in inflammatory bowel diseases - a new disease severity indicator?

Authors:  Z Vegh; T Bessissow; W Afif; P L Lakatos
Journal:  Aliment Pharmacol Ther       Date:  2017-04       Impact factor: 8.171

Review 3.  Extraintestinal Manifestations of Inflammatory Bowel Disease.

Authors:  Stephan R Vavricka; Alain Schoepfer; Michael Scharl; Peter L Lakatos; Alexander Navarini; Gerhard Rogler
Journal:  Inflamm Bowel Dis       Date:  2015-08       Impact factor: 5.325
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.